AURA
Price
$6.42
Change
-$0.25 (-3.75%)
Updated
Jun 13 closing price
Capitalization
398.07M
53 days until earnings call
DSGN
Price
$3.84
Change
-$0.07 (-1.79%)
Updated
Jun 13 closing price
Capitalization
217.99M
57 days until earnings call
Interact to see
Advertisement

AURA vs DSGN

Header iconAURA vs DSGN Comparison
Open Charts AURA vs DSGNBanner chart's image
Aura Biosciences
Price$6.42
Change-$0.25 (-3.75%)
Volume$152.63K
Capitalization398.07M
Design Therapeutics
Price$3.84
Change-$0.07 (-1.79%)
Volume$65.99K
Capitalization217.99M
AURA vs DSGN Comparison Chart
Loading...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AURA vs. DSGN commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a Hold and DSGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 16, 2025
Stock price -- (AURA: $6.42 vs. DSGN: $3.84)
Brand notoriety: AURA and DSGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 73% vs. DSGN: 56%
Market capitalization -- AURA: $398.07M vs. DSGN: $217.99M
AURA [@Biotechnology] is valued at $398.07M. DSGN’s [@Biotechnology] market capitalization is $217.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 0 FA rating(s) are green whileDSGN’s FA Score has 0 green FA rating(s).

  • AURA’s FA Score: 0 green, 5 red.
  • DSGN’s FA Score: 0 green, 5 red.
According to our system of comparison, AURA is a better buy in the long-term than DSGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 6 TA indicator(s) are bullish while DSGN’s TA Score has 5 bullish TA indicator(s).

  • AURA’s TA Score: 6 bullish, 2 bearish.
  • DSGN’s TA Score: 5 bullish, 1 bearish.
According to our system of comparison, DSGN is a better buy in the short-term than AURA.

Price Growth

AURA (@Biotechnology) experienced а -1.23% price change this week, while DSGN (@Biotechnology) price change was -4.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.63%. For the same industry, the average monthly price growth was +13.05%, and the average quarterly price growth was +4.06%.

Reported Earning Dates

AURA is expected to report earnings on Aug 07, 2025.

DSGN is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (-0.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AURA($398M) has a higher market cap than DSGN($218M). AURA YTD gains are higher at: -21.898 vs. DSGN (-37.763). DSGN has higher annual earnings (EBITDA): -67.79M vs. AURA (-101.63M). DSGN has more cash in the bank: 230M vs. AURA (128M). DSGN has less debt than AURA: DSGN (2.14M) vs AURA (18.4M). AURA (0) and DSGN (0) have equivalent revenues.
AURADSGNAURA / DSGN
Capitalization398M218M183%
EBITDA-101.63M-67.79M150%
Gain YTD-21.898-37.76358%
P/E RatioN/AN/A-
Revenue00-
Total Cash128M230M56%
Total Debt18.4M2.14M859%
TECHNICAL ANALYSIS
Technical Analysis
AURADSGN
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
78%
Momentum
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
71%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 19 days ago
76%
Bullish Trend 19 days ago
88%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
83%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
75%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TVLAX11.79-0.15
-1.26%
Touchstone Value A
MRERX49.44-0.69
-1.38%
MFS Core Equity R2
PMDDX17.85-0.28
-1.54%
Principal Small-MidCap Dividend Inc C
FAPHX12.80-0.28
-2.14%
Fidelity Healthy Future
HSEIX11.37-0.29
-2.49%
Hartford Small Cap Value I

AURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AURA has been loosely correlated with MGTX. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if AURA jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AURA
1D Price
Change %
AURA100%
-3.75%
MGTX - AURA
53%
Loosely correlated
+0.61%
IDYA - AURA
50%
Loosely correlated
-0.45%
VRDN - AURA
49%
Loosely correlated
+1.34%
BEAM - AURA
49%
Loosely correlated
-2.18%
XNCR - AURA
47%
Loosely correlated
-2.55%
More

DSGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been loosely correlated with TCRT. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if DSGN jumps, then TCRT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
-1.79%
TCRT - DSGN
56%
Loosely correlated
+2.40%
VRDN - DSGN
48%
Loosely correlated
+1.34%
AURA - DSGN
45%
Loosely correlated
-3.75%
IDYA - DSGN
45%
Loosely correlated
-0.45%
KRYS - DSGN
44%
Loosely correlated
-2.32%
More